Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Proscia updates digital pathology platform

Proscia
By Author Proscia | November 29, 2022

Proscia has introduced a new version of its Concentriq Dx digital pathology platform for primary diagnostic workflows.

*Concentriq Dx is CE-marked under IVDR and is available for primary diagnosis in the US during the COVID-19 public health emergency.

Our website uses cookies. By using this site, you agree to its use of cookies.